01
Individual Assessment
Each eye is evaluated individually rather than treated according to a universal preset or eye-color category.
PHYSICIAN-LED OPHTHALMIC CARE
Why Trust MyLumineyes®?
Trust in medical care should be based on clinical experience, transparent information, realistic expectations and responsible long-term ophthalmic follow-up — not on promises of a particular cosmetic result.
Our approach is built around individualized assessment,
biological variability, careful treatment planning and continued
observation of the eye over time.
01
Physician LedClinical decisions remain under ophthalmic evaluation and supervision.
02
Long-Term ExperienceMore than 25 years of clinical ophthalmology experience.
03
Evidence AwareClinical observations are presented together with their limitations.
04
Patient SpecificTreatment planning reflects individual anatomy and biological response.
QUICK ANSWER
MyLumineyes® approaches trust as a matter of
clinical responsibility rather than marketing:
appropriate patient selection, transparent discussion of uncertainty
and risks, individualized treatment planning, ophthalmic monitoring,
and long-term clinical observation.
01 — CLINICAL APPROACH
Who We Are
MyLumineyes® was founded around a straightforward clinical principle: patients should receive accurate information, realistic expectations, individualized assessment and treatment planning that places ocular health ahead of cosmetic expectations.
No two irides, medical histories or biological responses are identical. Suitability therefore cannot be determined from desired eye color alone. Clinical assessment considers ocular findings, iris characteristics, treatment expectations and factors relevant to responsible follow-up.
Explore the Lumineyes Method →02 — WHY PATIENTS TRUST US
Clinical principles before cosmetic promises.
Responsible eye-color treatment requires clear boundaries. A desired shade cannot override anatomy, ocular findings, biological variability or clinical judgment.
02
Transparent Expectations
Exact final color and a fixed treatment course cannot be promised from baseline eye color alone.
03
Clinical Monitoring
Treatment decisions are informed by ophthalmic findings and the observed response of the individual eye.
04
Safety Boundaries
Treatment may be declined or modified when clinical findings or expectations are not compatible with responsible care.
03 — THE PHYSICIAN
Clinical responsibility has a name.
Dr. Mustafa Mete is an ophthalmologist and clinical researcher whose work includes iris pigmentation, laser iris depigmentation, ophthalmic assessment, treatment monitoring and long-term follow-up.
His broader clinical background spans more than 25 years in ophthalmology, while his work with the Lumineyes® approach extends over more than 15 years.
View Physician Profile →04 — EVIDENCE & EXPERIENCE
Trust requires more than a claim.
Clinical experience, documented patient outcomes, long-term observation and published evidence are different forms of information. They should not be presented as if they were interchangeable. MyLumineyes® aims to distinguish clinical observation from broader scientific evidence and to communicate the limitations of each.
Direct Clinical Experience
Treatment planning is informed by direct ophthalmic evaluation and accumulated clinical observation of iris response.
Long-Term Observation
Long-term patient relationships allow outcomes and ocular findings to be observed beyond the immediate treatment period.
Research With Limits
Clinical observations are not a substitute for independent, controlled evidence. Research limitations should remain visible when outcomes are discussed.
05 — MEDICAL ETHICS
What we will not promise.
Ethical communication is especially important when a medical intervention is sought for cosmetic reasons. Patient expectations should never be presented as guaranteed biological outcomes.
01
No guaranteed final shade
Individual biological response and color perception vary.
02
No session count based on color alone
Treatment course depends on clinical characteristics and response.
03
No treatment at any cost
Unsuitable candidates may be declined on clinical grounds.
04
No concealment of uncertainty
Risks, limitations and evidence boundaries should be discussed openly.
06 — LONG-TERM RELATIONSHIPS
Clinical follow-up does not end with a photograph.
One of the most valuable aspects of long-term clinical practice is continued contact with patients after treatment. Follow-up allows clinical observations to extend beyond the immediate visual result and provides a broader view of the individual treatment course.
Before-and-after images are useful documentation, but they are not
substitutes for ophthalmic assessment, longitudinal follow-up or
appropriately designed clinical research.
View Clinical Cases →
PHYSICIAN IDENTITY & RESEARCH
Verify the medical reviewer.
Medical content should make its clinical reviewer identifiable. Dr. Mustafa Mete's physician profile provides professional context, while his ORCID record provides an external research identity.
07 — INFORMED DECISIONS
Understand the procedure before deciding.
Learn about the clinical approach, treatment limitations, patient eligibility, potential risks and available evidence before considering laser eye color change.